Pathology of AIHA, for neet pg 2026, cover everything that can come for this exam

Reading Document
Medical Text Search

autoimmune hemolytic anemia AIHA classification pathology warm cold antibody

Medical Text Search

AIHA Coombs test direct indirect antiglobulin hemolysis mechanism lab findings

GradeResponse
GradeResponse
Medical Text Search

warm AIHA IgG extravascular hemolysis spleen pathophysiology Fc receptor macrophage

Medical Text Search

cold agglutinin disease IgM complement intravascular hemolysis paroxysmal cold hemoglobinuria Donath-Landsteiner

I have sufficient retrieved content plus comprehensive knowledge. Here is a complete NEET PG 2026-focused breakdown of AIHA pathology:

Autoimmune Hemolytic Anemia (AIHA) — Complete Pathology for NEET PG 2026


1. Definition & Overview

AIHA is a condition in which autoantibodies directed against red cell antigens cause premature RBC destruction (hemolysis). Incidence ~1–3:100,000/year; prevalence ~17:100,000. Mortality ~5–10% even with treatment (Harrison's, p. 3014).

2. Classification (Most Exam-Important)

TypeAntibodyIg ClassOptimal Reactivity TempMechanism of Hemolysis
Warm AIHAWarm antibodyIgG (rarely IgA)37°CExtravascular (spleen)
Cold Agglutinin Disease (CAD)Cold antibodyIgM0–4°C (reacts up to 30°C)Extravascular (liver) + Intravascular
Paroxysmal Cold Hemoglobinuria (PCH)Donath-Landsteiner AbIgG (biphasic)Cold → 37°CIntravascular (complement)
Drug-induced AIHAVariesIgG/IgMVariableVariable
Mixed AIHABoth warm + coldIgG + IgMBothBoth

3. Warm AIHA — Detailed Pathology

Etiology

  • Primary (Idiopathic): ~50% of cases
  • Secondary:
    • Lymphoproliferative: CLL (most common), NHL, Hodgkin lymphoma
    • Autoimmune: SLE (most important), RA, IBD
    • Infections: EBV, HIV
    • Drugs: methyldopa, fludarabine
    • Solid tumors (rare)

Antibody Characteristics

  • IgG (subtypes IgG1, IgG3 are most hemolytic)
  • Non-complement fixing (usually) — does NOT activate complement fully
  • Directed against Rh antigens most commonly (pan-agglutinin — reacts with all Rh+ cells)
  • React best at 37°C

Mechanism of Hemolysis (EXTRAVASCULAR)

  1. IgG antibodies coat the RBC surface
  2. Coated RBCs travel to spleen
  3. Splenic macrophages recognize IgG via Fc receptors (FcγRIII)
  4. Macrophages partially phagocytose the RBC membrane → microspherocytes form
  5. Microspherocytes are rigid, trapped in splenic sinusoids → destroyed
  6. Result: extravascular hemolysissplenomegaly
  7. If IgG1/IgG3 + complement activation → C3b on RBC → Kupffer cells in liver (via CR1) also destroy RBCs
Key point for MCQs: Warm AIHA → IgG → Spleen → Extravascular hemolysis → Microspherocytes

Lab Findings

  • Anemia (normocytic/macrocytic if compensated)
  • Reticulocytosis (usually — but can have reticulocytopenia in severe cases)
  • Peripheral smear: Microspherocytes (most characteristic), polychromasia
  • Raised LDH, raised indirect bilirubin, raised urobilinogen
  • Low/absent haptoglobin
  • Direct Coombs test (DAT) POSITIVE for IgG ± C3
  • Indirect Coombs test (IAT): may be positive (free antibody in serum)

Direct Antiglobulin Test (DAT / Direct Coombs Test)

(Harrison's, p. 3015)
  • Developed by R.R.A. Coombs in 1945
  • Uses broad-spectrum reagent detecting both Ig AND complement (C3 fragments) on RBC surface
  • Positive if ≥400 molecules of Ig/C3 per RBC
  • Practically diagnostic of AIHA when positive (barring recent transfusion)
  • In Warm AIHA: IgG positive ± C3 positive
  • Advanced techniques (flow cytometry) detect even lower coating levels
TestWhat it detectsPositive in
Direct Coombs (DAT)Antibody/complement on patient's RBCAIHA, HDN, drug-induced hemolysis
Indirect Coombs (IAT)Antibody in patient's serum reacting with donor RBCsCrossmatching, HDN screening

4. Cold Agglutinin Disease (CAD)

Etiology

  • Primary (Idiopathic): Chronic CAD in elderly
  • Secondary:
    • Mycoplasma pneumoniae → anti-I antibody (IgM)
    • Infectious mononucleosis (EBV) → anti-i antibody (IgM)
    • Lymphoproliferative disease (Waldenström macroglobulinemia)

Antibody Characteristics

  • IgM (pentameric — very efficient at complement fixation)
  • Directed against I antigen (Mycoplasma, primary CAD) or i antigen (EBV)
  • Reacts at 0–4°C, thermal amplitude up to 30°C (pathological if >30°C)

Mechanism

  1. In peripheral cold areas (acral regions): IgM binds I/i antigen → activates complement (C1→C4b2a→C3b deposited)
  2. IgM detaches as blood warms (it's reversible at 37°C)
  3. RBCs coated with C3bliver (Kupffer cells) via CR1 → extravascular hemolysis
  4. If complement cascade goes to completion → MAC (C5b-9)intravascular hemolysis + hemoglobinuria

DAT Result

  • C3d POSITIVE, IgG NEGATIVE (IgM washes off during test; only C3 fragments remain)

Clinical Features

  • Acrocyanosis (fingers, toes, ears, nose turn blue/purple in cold)
  • Hemolysis worsens in cold weather
  • Raynaud phenomenon
  • Mild chronic anemia

5. Paroxysmal Cold Hemoglobinuria (PCH)

Key Facts (HIGH YIELD)

  • Rarest type of AIHA
  • Classically associated with syphilis (tertiary/congenital); now more common post-viral infections in children
  • Antibody: Donath-Landsteiner (DL) antibodyIgG, biphasic

Donath-Landsteiner Antibody (MUST KNOW)

PhaseTemperatureEvent
Cold phase (0–15°C)ColdIgG binds P antigen on RBC → fixes complement (C1–C3)
Warm phase (37°C)WarmComplement cascade completes → MAC → intravascular hemolysis
  • Directed against P antigen on RBCs
  • Biphasic hemolysis: antibody binds in cold, hemolysis occurs on rewarming
  • DAT: C3 positive, IgG may be weakly positive or negative (IgG detaches)
  • Hemoglobinuria after cold exposure (paroxysmal)
  • Donath-Landsteiner test: specific diagnostic test

6. Drug-Induced AIHA

Three Mechanisms (Classic NEET Topic)

MechanismPrototype DrugAntibodyDATMechanism
Hapten/Drug adsorptionPenicillin (high dose)IgG anti-drugIgG positiveDrug binds RBC → IgG directed against drug-RBC complex → extravascular
Immune complex (Innocent bystander)Quinidine, quinine, rifampicinIgM or IgGC3 positiveDrug-Ab complex adsorbs onto RBC → complement activation → intravascular
Autoantibody inductionMethyldopa (α-methyldopa)IgG anti-RhIgG positiveDrug alters RBC surface → true autoantibody formed → indistinguishable from warm AIHA
Methyldopa: 15–20% develop positive DAT; only 1% develop actual hemolysis. Antibody is directed at Rh antigens.

7. Peripheral Blood Smear Findings

FindingSignificance
MicrospherocytesHallmark of warm AIHA (partial phagocytosis)
PolychromasiaReticulocytosis (compensatory)
Agglutination of RBCsCold agglutinin disease
Nucleated RBCsSevere hemolysis
Ghost cells / fragmented RBCsNOT typical of AIHA (more TTP/HUS/DIC)

8. Summary of DAT Results (Ultra High-Yield Table)

AIHA TypeIgGC3
Warm AIHA✅ Positive±
Cold Agglutinin Disease❌ Negative✅ Positive
PCHWeakly + / ❌✅ Positive
Drug (hapten)✅ Positive
Drug (immune complex)✅ Positive
Drug (methyldopa)✅ Positive

9. General Lab Features of Hemolytic Anemia (All AIHA Types)

ParameterFinding
HemoglobinLow
MCVElevated (reticulocytes are large)
Reticulocyte countHigh (reticulocytosis)
Peripheral smearSpherocytes, polychromasia
Serum LDHElevated
Serum bilirubin (indirect)Elevated
Serum haptoglobinLow/absent (binds free Hb)
Urine urobilinogenElevated
Urine hemoglobinPresent only in intravascular hemolysis (PCH, severe CAD)
Urine hemosiderinIn chronic intravascular hemolysis
Bone marrowErythroid hyperplasia

10. Treatment Overview (for Context)

TypeTreatment
Warm AIHASteroids (prednisolone 1 mg/kg) = first line; Rituximab, splenectomy
CADAvoid cold; Rituximab ± bendamustine; steroids ineffective
PCHTreat underlying cause; avoid cold; usually self-limiting in children
Drug-inducedStop the offending drug

11. Exam-Specific One-Liners

  • Warm AIHA: IgG, 37°C, extravascular, spleen, microspherocytes, DAT IgG+
  • Cold agglutinitis: IgM, cold, complement-mediated, liver, DAT C3+ only, anti-I (Mycoplasma) / anti-i (EBV)
  • PCH: IgG biphasic, P antigen, Donath-Landsteiner Ab, syphilis/post-viral, intravascular, DAT C3+
  • Coombs test (1945, Coombs) = positive = diagnostic of AIHA
  • DAT = detects Ab ON patient RBC; IAT = detects Ab IN patient serum
  • Methyldopa: 15–20% positive DAT, only 1% actual hemolysis, anti-Rh
  • Quinidine: innocent bystander, C3+, intravascular hemolysis
  • Penicillin (high dose): hapten mechanism, IgG+, extravascular
  • Microspherocytes in AIHA = partial splenic phagocytosis (NOT osmotic fragility like hereditary spherocytosis, though osmotic fragility IS increased in both)
  • Reticulocytopenia in AIHA = parvovirus B19 co-infection or autoantibodies against reticulocytes → aplastic crisis

12. Associations to Remember for MCQs

AssociationAIHA Type
SLEWarm AIHA
CLLWarm AIHA (most common secondary cause)
Mycoplasma pneumoniaeCold Agglutinin (anti-I IgM)
EBV / Infectious MononucleosisCold Agglutinin (anti-i IgM)
Waldenström macroglobulinemiaCold Agglutinin (monoclonal IgM)
Syphilis (tertiary)PCH (Donath-Landsteiner)
Post-viral in childrenPCH
MethyldopaDrug AIHA (autoantibody type)
FludarabineWarm AIHA
Evan's syndromeWarm AIHA + Immune thrombocytopenia (ITP)

This covers every angle that NEET PG 2026 can test on AIHA pathology — mechanisms, antibody types, Coombs testing, peripheral smear, drug-induced variants, and clinical associations. Focus especially on the DAT result table and the Donath-Landsteiner test for PCH, as these are consistent high-yield MCQ targets.
This is a shared conversation. Sign in to Orris to start your own chat.